These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10150492)

  • 1. Safety of propellants.
    Alexander DJ
    J Aerosol Med; 1995; 8 Suppl 1():S29-34. PubMed ID: 10150492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of CFC-free metered dose inhalers.
    Jenkins M
    J Aerosol Med; 1995; 8 Suppl 1():S41-7. PubMed ID: 10150495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).
    Alexander DJ; Libretto SE
    Hum Exp Toxicol; 1995 Sep; 14(9):715-20. PubMed ID: 8579881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
    Pike VW; Aigbirhio FI; Freemantle CA; Page BC; Rhodes CG; Waters SL; Jones T; Olsson P; Ventresca GP; Tanner RJ
    Drug Metab Dispos; 1995 Aug; 23(8):832-9. PubMed ID: 7493550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFC replacements: safety testing, approval for use in metered dose inhalers.
    Graepel P; Alexander DJ
    J Aerosol Med; 1991; 4(3):193-200. PubMed ID: 10147679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition to CFC-free metered dose inhalers--into the new millennium.
    McDonald KJ; Martin GP
    Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing patient care with metered-dose inhalers.
    Woodcock A
    J Aerosol Med; 1995; 8 Suppl 2():S5-10. PubMed ID: 10155357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute, repeated inhalation toxicity, respiratory system irritation, and mutagenicity studies of 1,1,2,2-tetrafluoroethane (HFC-134) as the impurity in the pharmaceutical propellant 1,1,1,2-tetrafluoroethane (HFA-134a).
    Zhao Y; Sun H; Lin F; Yang H
    Drug Chem Toxicol; 2023 Nov; 46(5):841-850. PubMed ID: 35920286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects.
    Harrison LI; Donnell D; Simmons JL; Ekholm BP; Cooper KM; Wyld PJ
    J Pharm Pharmacol; 1996 Jun; 48(6):596-600. PubMed ID: 8832493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers.
    Kirby SM; Smith J; Ventresca GP
    Thorax; 1995 Jun; 50(6):679-81. PubMed ID: 7638815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canister valve and actuator deposition in metered dose inhalers formulated with low-GWP propellants.
    Duke DJ; Rao L; Kastengren A; Myatt B; Cocks P; Stein S; Marasini N; Ong HX; Young P
    Int J Pharm; 2023 Dec; 648():123569. PubMed ID: 37925043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.